Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc

<< Previous

Bullboard Posts

Next >>

Post by pm1861on Dec 02, 2023 5:38pm

357 Views

Post# 35765434

What does this all mean?

Let's examine the Management Circular from the Annual Meeting

Page 26

"The employment agreement of Mr. McInnis does not include a termination following a change of control provision."

His Options

Page 22

"For Mr. McInnis ii) 437,124 Options vested at one quarter of the grant amount at the time of the grant of April 5, 2022 and the balance vests equally as to one-twelfth on each quarter and will be fully vested on April 5, 2027"

He has 180 days to pick up any of his vested options.

Choose your own adventure.

PM

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal